| Canadian best practice recommendations for the management of amyotrophic lateral sclerosis C Shoesmith, A Abrahao, T Benstead, M Chum, N Dupre, A Izenberg, ... Cmaj 192 (46), E1453-E1468, 2020 | 68 | 2020 |
| Challenges facing palliative neurology practice: a qualitative analysis TE Gofton, M Chum, V Schulz, BT Gofton, A Sarpal, C Watling Journal of the Neurological Sciences 385, 225-231, 2018 | 42 | 2018 |
| Motor and visual codes interact to facilitate visuospatial memory performance M Chum, H Bekkering, MD Dodd, J Pratt Psychonomic bulletin & review 14 (6), 1189-1193, 2007 | 38 | 2007 |
| Electrodiagnostic characterization of hereditary neuropathy with liability to pressure palsies S Takahashi, M Chum, K Kimpinski Journal of Clinical Neuromuscular Disease 18 (3), 119-124, 2017 | 21 | 2017 |
| Traumatic tiger attack: case report M Chum, WP Ng Journal of Neurosurgery: Pediatrics 8 (5), 530-534, 2011 | 16 | 2011 |
| MRI-visible perivascular space volumes, sleep duration and daytime dysfunction in adults with cerebrovascular disease J Ramirez, MF Holmes, C Berezuk, D Kwan, B Tan, D Beaton, CJM Scott, ... Sleep Medicine 83, 83-88, 2021 | 14 | 2021 |
| ALK-negative CNS anaplastic large cell lymphoma: Case report and review of literature M Lannon, JQ Lu, M Chum, BH Wang British Journal of Neurosurgery 37 (5), 1245-1250, 2023 | 13 | 2023 |
| Genetic testing for amyotrophic lateral sclerosis in Canada–an assessment of current practices K Salmon, N Anoja, A Breiner, M Chum, A Dionne, N Dupré, A Fiander, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23 (3-4), 305-312, 2022 | 12 | 2022 |
| Do generic preference-based measures accurately capture areas of health-related quality of life important to individuals with amyotrophic lateral sclerosis: a content … N Peters, V Dal Bello-Haas, T Packham, M Chum, C O’Connell, ... Patient related outcome measures, 191-203, 2021 | 7 | 2021 |
| A case of severe early-onset neuropathy caused by a compound heterozygous deletion of the PMP22 gene: clinical and neurographic aspects S D'Arrigo, V Tessarollo, F Taroni, S Baratta, C Pantaleoni, E Schiaffi, ... Neuropediatrics 51 (03), 173-177, 2020 | 7 | 2020 |
| Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseases M Ozzoude, B Varriano, D Beaton, J Ramirez, MF Holmes, CJM Scott, ... Geroscience 44 (3), 1575-1598, 2022 | 5 | 2022 |
| Refining items for a preference-based, amyotrophic lateral sclerosis specific, health-related quality of life scale J Van Damme, A Kuspinar, W Johnston, C O’Connell, J Turnbull, M Chum, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23 (7-8), 508-516, 2022 | 4 | 2022 |
| Trainee distress when faced with end-of-life care in neurology: a qualitative analysis K Kazazian, M Chum, TE Gofton Canadian Journal of Neurological Sciences 50 (1), 83-88, 2023 | 1 | 2023 |
| Retinal nerve fiber layer in frontotemporal lobar degeneration and amyotrophic lateral sclerosis BM Wong, C Hudson, E Snook, F Tayyari, H Jung, MA Binns, S Samet, ... Frontiers in Neuroscience 16, 964715, 2022 | 1 | 2022 |
| The value of nerve biopsy in transthyretin amyloidosis with competing comorbidities G Mak, M Chum, JQ Lu Canadian Journal of Neurological Sciences 49 (5), 725-727, 2022 | 1 | 2022 |
| Recommandations canadiennes pour les pratiques optimales de prise en charge de la sclérose latérale amyotrophique C Shoesmith, A Abrahao, T Benstead, M Chum, N Dupre, A Izenberg, ... CMAJ 192 (46), E1505-E1521, 2020 | 1 | 2020 |
| Canadian ALS best practice recommendations (2749) C Shoesmith, A Abrahao, T Benstead, M Chum, N Dupre, A Izenberg, ... Neurology 94 (15 Supplement), 2020 | 1 | 2020 |
| E. 11 Non-invasive ventilation in patients with amyotrophic lateral sclerosis: practice patterns amongst Canadian care providers MC Chum, T Gofton, C Shoesmith Canadian Journal of Neurological Sciences 43 (S2), S18-S18, 2016 | 1 | 2016 |
| Phase 3B study evaluating superiority of daily dosing vs approved on/off oral edaravone dosing over 48 weeks in patients with amyotrophic lateral sclerosis (MT-1186-A02) A Salah, S Desilva, L Zinman, M Chum, A Chio, AC Ludolph, G Sobue, ... Journal of the Neurological Sciences 455, 2023 | | 2023 |
| Phase 3B extension study evaluating superiority of daily vs approved on/off oral edaravone dosing in patients with amyotrophic lateral sclerosis J Rothstein, S Desilva, L Zinman, M Chum, A Chio, AC Ludolph, G Sobue, ... Journal of the Neurological Sciences 455, 2023 | | 2023 |
